[PHP39] Drug Pricing Reform in China – An Analysis of Piloted Pricing Approaches in the Context of International Experience

[PHP39] Drug Pricing Reform in China – An Analysis of Piloted Pricing Approaches in the Context of International Experience

2015 Value in Health

Chen, Y. | Dong, P. | Yan, J. | Kornfeld, A. | Jaros, P. | Ma, F. | Toumi, M. | Volume: 18, Issue: 7, Pages: A521,

Since 2009, the Chinese government has launched a global healthcare reform program aiming to control healthcare expenditure and increase the quality of care. As a part of this program, a new drug pricing reform was initiated starting 1stJune 2015. The objective of this study is to describe the changing landscape of drug pricing policy in China.

https://www.doi.org/10.1016/j.jval.2015.09.1593